Carcinoma, Squamous Cell: all 1,779 studies

Page 6 of 18. Open to participants first (409), then studies with results posted, then the rest; newest registration first within each.

• Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress MarkersActive, not recruitingNCT02994069Phase 2Results posted
• Pembrolizumab in Patients With Locally Advanced or Metastatic Skin CancerCompletedNCT02964559Phase 2Results posted
• Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)TerminatedNCT02952586Phase 3Results posted
• Phase I/II Study OF Metformin in Combination With Cisplatin and Radiation in Head and Neck Squamous Cell CarcinomaCompletedNCT02949700Phase 1/2Results posted
• Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical CancerCompletedNCT02921269Phase 2Results posted
• ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive TreatmentTerminatedNCT02917629Phase 2Results posted
• Preoperative Chemoradiotherapy and MK-3475 for Esophageal Squamous Cell Carcinoma (ACTS-29)CompletedNCT02844075Phase 2Results posted
• Trial of Pembrolizumab for Advanced Penile Squamous Cell CarcinomaTerminatedNCT02837042Phase 2Results posted
• A Study of TAK-659 in Combination With Nivolumab in Participants With Advanced Solid TumorsTerminatedNCT02834247Phase 1Results posted
• Pembrolizumab and Palliative Radiation Therapy in Treating Patients With Metastatic Esophagus, Stomach, or Gastroesophageal Junction CancerCompletedNCT02830594Phase 2Results posted
• Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx CancerTerminatedNCT02827838Early Phase 1Results posted
• Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT02823574Phase 2Results posted
• PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and NeckTerminatedNCT02819752Phase 1Results posted
• Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell CancerCompletedNCT02784288Phase 2Results posted
• Pembrolizumab in Combination With Cisplatin and Intensity Modulated Radiotherapy (IMRT) in Head and Neck CancerCompletedNCT02777385Phase 2Results posted
• Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell CarcinomaCompletedNCT02760498Phase 2Results posted
• A Study of Chemoradiation Plus Pembrolizumab for Locally Advanced Laryngeal Squamous Cell CarcinomaCompletedNCT02759575Phase 1/2Results posted
• Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT02741570Phase 3Results posted
• Study of Glembatumumab Vedotin in gpNMB-Expressing, Advanced or Metastatic SCC of the LungTerminatedNCT02713828Phase 1/2Results posted
• BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck CancerTerminatedNCT02706691Phase 2Results posted
• Screening Trial of Nivolumab With Image Guided, Stereotactic Body Radiotherapy (SBRT) Versus Nivolumab Alone in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)CompletedNCT02684253Phase 2Results posted
• SF1126 in Recurrent or Progressive SCCHN and Mutations in PIK3CA Gene and/or PI-3 Kinase Pathway GenesTerminatedNCT02644122Phase 2Results posted
• Patritumab With Cetuximab and a Platinum Agent for Squamous Cell Carcinoma (Cancer) of the Head and Neck (SCCHN )TerminatedNCT02633800Phase 2Results posted
• Talimogene Laherparepvec With Pembrolizumab for Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY232 / KEYNOTE-137)CompletedNCT02626000Phase 1Results posted
• IRX-2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral CavityCompletedNCT02609386Phase 2Results posted
• Pembrolizumab in Combination With CRT for LA-SCCHNCompletedNCT02586207Phase 1Results posted
• Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)CompletedNCT02573493Phase 2Results posted
• Trial Using Gilotrif for Advanced Penile Squamous Cell CarcinomaTerminatedNCT02541903Phase 2Results posted
• Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by SurgeryCompletedNCT02538510Phase 1/2Results posted
• Docetaxel and Capecitabine With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckTerminatedNCT02524275Phase 2Results posted
• A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaTerminatedNCT02521870Phase 1/2Results posted
• Safety And Efficacy Study Of Palbociclib Plus Cetuximab Versus Cetuximab To Treat Head And Neck CancerCompletedNCT02499120Phase 2Results posted
• Study of SCB01A in Patient With Head and Neck CancerTerminatedNCT02488629Phase 2Results posted
• Study of the Combination of Acalabrutinib (ACP-196) and Pembrolizumab in Advanced Head and Neck Squamous Cell CarcinomaCompletedNCT02454179Phase 2Results posted
• Sapanisertib in Treating Patients With Stage IV or Recurrent Lung CancerCompletedNCT02417701Phase 2Results posted
• Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck CancerTerminatedNCT02388932Not applicableResults posted
• Phase III Trial to Assess Efficacy and Safety of Cetuximab for the Treatment of Chinese Participants With Head and Neck CancerCompletedNCT02383966Phase 3Results posted
• Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS MutationsCompletedNCT02383927Phase 2Results posted
• Study of MEDI4736 Monotherapy and in Combination With Tremelimumab Versus Standard of Care Therapy in Patients With Head and Neck CancerCompletedNCT02369874Phase 3Results posted
• Preventing Squamous Cell Skin CancerCompletedNCT02347813Phase 2Results posted
• Trial of pIL-12 Electroporation in Squamous Cell Carcinoma of the Head and Neck (IL12HNSCC)TerminatedNCT02345330Phase 2Results posted
• Dose-finding Study of Metformin With Chemoradiation in Locally Advanced Head and Neck Squamous Cell CarcinomaCompletedNCT02325401Phase 1Results posted
• Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin CancerCompletedNCT02324608Not applicableResults posted
• Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and NeckCompletedNCT02319044Phase 2Results posted
• Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and NeckCompletedNCT02289209Phase 2Results posted
• De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up StudyCompletedNCT02281955Phase 2Results posted
• Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal CancerCompletedNCT02258659Phase 2Results posted
• Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)CompletedNCT02255097Phase 2Results posted
• Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)CompletedNCT02252042Phase 3Results posted
• Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell CarcinomaCompletedNCT02218164Phase 2Results posted
• Selinexor Treatment of Advanced Relapsed/Refractory Squamous Cell CarcinomasTerminatedNCT02213133Phase 2Results posted
• Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT02207530Phase 2Results posted
• Phase II Trial of Nelfinavir With Concurrent Chemoradiotherapy in Squamous Cell Carcinoma of the Head and NeckCompletedNCT02207439Phase 2Results posted
• Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck CancerTerminatedNCT02196168Phase 2Results posted
• Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck CancerTerminatedNCT02177838Not applicableResults posted
• Study of HPV Specific Immunotherapy in Participants With HPV Associated Head and Neck Squamous Cell CarcinomaCompletedNCT02163057Phase 1/2Results posted
• Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade LesionsCompletedNCT02135419Phase 3Results posted
• Weekly Carboplatin, Paclitaxel and Cetuximab Treatment for Patients With Recurrent or Metastatic SCCHNCompletedNCT02124707Phase 2Results posted
• Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation TherapyCompletedNCT02123511Phase 2Results posted
• Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and NeckCompletedNCT02113878Phase 1Results posted
• Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141)CompletedNCT02105636Phase 3Results posted
• PD 0332991 and Cetuximab in Patients With Incurable SCCHNCompletedNCT02101034Phase 1/2Results posted
• Treatment With Nab-paclitaxel in Cutaneous SCCTerminatedNCT02076243Phase 2Results posted
• The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma (SCCA) (SIRS TRIAL)CompletedNCT02072148Not applicableResults posted
• Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck CancerTerminatedNCT02068157Phase 2Results posted
• Randomized Study of Beet Root in Locally Advanced Squamous Cell Cancer of the Head and NeckCompletedNCT02058849Phase 2Results posted
• CetuGEX™ in Comparison to Cetuximab for the Treatment of Patients With Head and Neck CancerCompletedNCT02052960Phase 2Results posted
• Radiofrequency Ablation for Patients With Esophageal Squamous Cell NeoplasiaCompletedNCT02047305Not applicableResults posted
• Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing SurgeryCompletedNCT02007200Phase 2Results posted
• ADXS 11-001 Vaccination Prior to Robotic Surgery, HPV-Positive Oropharyngeal CancerCompletedNCT02002182Phase 2Results posted
• Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid TumorsCompletedNCT02001623Phase 1/2Results posted
• Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC)TerminatedNCT01984892Phase 2Results posted
• Post-operative Radiation With Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckCompletedNCT01979211Phase 2Results posted
• Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSILCompletedNCT01928225Phase 2Results posted
• OPSCC N0 Nodal Control With Reduced IMRTTerminatedNCT01891695Not applicableResults posted
• Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum TherapyTerminatedNCT01852292Phase 2Results posted
• Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT01836029Phase 2Results posted
• Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of RecurrenceTerminatedNCT01824823Phase 2Results posted
• Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the SkinTerminatedNCT01823679Phase 2Results posted
• PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT01816984Phase 1/2Results posted
• 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyCompletedNCT01806675Phase 1/2Results posted
• Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck CarcinomaTerminatedNCT01794845Phase 2Results posted
• Use of Pharmacogenetics to Select Erbitux or Cisplatin to Treat Head and Neck CancerTerminatedNCT01790516Not applicableResults posted
• Study of Olaparib With Radiation Therapy and Cetuximab in Advanced Head and Neck Cancer With Heavy Smoking HistoryCompletedNCT01758731Phase 1Results posted
• Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal CancerCompletedNCT01748942Not applicableResults posted
• A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC.TerminatedNCT01732640Phase 1/2Results posted
• Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck CancerCompletedNCT01711541Phase 1/2Results posted
• The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx CancerActive, not recruitingNCT01706939Phase 3Results posted
• A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive TractCompletedNCT01697800Phase 2Results posted
• Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation TherapyTerminatedNCT01682031Phase 2Results posted
• Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral SurgeryCompletedNCT01612351Phase 2Results posted
• A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaTerminatedNCT01602315Phase 1/2Results posted
• Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the VulvaStatus unknownNCT01595061Phase 2Results posted
• Radiation and Cetuximab Plus Intratumoral EGFR Antisense DNA in Locally Advanced Head and Neck Squamous Cell CarcinomaCompletedNCT01592721Phase 1/2Results posted
• Bevacizumab/Ph 2 for Locally Advanced Head and Neck CancerCompletedNCT01588431Phase 2Results posted
• Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the AnusCompletedNCT01581840Phase 1/2Results posted
• GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell CancerCompletedNCT01553851Phase 2Results posted
• De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell CaCompletedNCT01530997Phase 2Results posted
• Cetuximab and Dasatinib in Recurrent Squamous Cell CarcinomaTerminatedNCT01488318Phase 2Results posted
• Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck CancerCompletedNCT01469546Phase 2Results posted

← Carcinoma, Squamous Cell overview